QOL of Women With HR-Positive Metastatic BC Treated in the First-line Setting: Comparison Between Public and Private Institutions.
NCT ID: NCT05287139
Last Updated: 2022-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
202 participants
OBSERVATIONAL
2021-07-14
2022-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life After Conservative Oncoplastic Surgery in Breast Cancer Patients (IRONY: lIfe afteR ONcoplastic surgerY)
NCT05842148
Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment
NCT07191496
Local and Regional Radiotherapy for Nipple Sparing Mastectomy With Implant
NCT05213962
The Oncological Safety and Cosmetic Outcome of Areola Sparing Mastectomy : a Single Arm, Prospective, Cohort Study
NCT03105570
Local Therapy for ER/PR-positive Oligometastatic Breast Cancer
NCT04698252
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospital Beneficência Portuguesa de SP - BP1
Patients from private institutions.
Quality of Life
Assessment of patients' quality of life using the EORTC QLQ-C30 and EORTC-QLQ-BR 23 questionnaires
Hospital Pérola Byington - HPB2
Patients from public institutions.
Quality of Life
Assessment of patients' quality of life using the EORTC QLQ-C30 and EORTC-QLQ-BR 23 questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quality of Life
Assessment of patients' quality of life using the EORTC QLQ-C30 and EORTC-QLQ-BR 23 questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female patients ≥ 18 years of age;
* Patients diagnosed with hormone receptor positive, human epidermal growth factor receptor-type 2 -negative metastatic breast cancer; in first-line treatment (metastatic de novo disease or patients with recurrence during adjuvant endocrine therapy).
* First-line treatment can be considered as cytotoxic chemotherapy, isolated endocrine therapy or endocrine therapy in combination with 4/6 cyclin inhibitors.
* Patients on treatment for at least three (3) months and no more than eighteen (18) months.
* Have performance status Eastern Cooperative Oncology Group (ECOG scale) of 0-2.
* Do not present other concomitant neoplasms.
Exclusion Criteria
* Illiterate patients, with low levels of education or cognitive deficits that make it difficult to answer the questions of the data collection instrument.
* Patients with life expectancy \<3 months.
* Treatment with any product under investigation during the last 28 days.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beneficência Portuguesa de São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Debora de Melo Gagliato Jardim
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Débora G Jardim, MD
Role: PRINCIPAL_INVESTIGATOR
Beneficência Portuguesa de São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Pérola Byington
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BRAVE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.